Market Signals

Anthropic S-1: Record Growth, but is the IPO a Buy?

How Earnings Miss Will Impact PSEG Stock Investors

Meituan releases a new model with 1.6 trillion parameters, its general-purpose Agent test surpasses Opus-5, with special optimization for domestic chi

Loan growth, fall in provisions help SBI profits in Q2

Trump contesting midterm results is a tail risk the market has to price, not a base case. Watch volatility and risk appetite, the legal fight itself i

Binance deposits overtake withdrawals, and the SEC creates crypto FAQs on governance

RVTY Q3 Earnings Beat Estimates on Life Sciences Strength, '26 View Up

Leidos' Q3 Earnings Beat Estimates, Revenues Miss, '26 EPS View Raised

4 Defense Stocks Poised to Beat Expectations This Earnings Season

ED attaches 2 planes, land, windmills worth Rs 510 crore of Anil Ambani's group

The S&P 500 snapped a three-day skid on Election Day as chip stocks rebounded. Semis doing the lifting makes it a relief bounce, not a broad risk-on c

Recursion's Q3 Earnings Beat Estimates on Sanofi Milestone Revenues

New national home listing database is taking on Compass in the battle for control of real estate information

Shopify falls 7% after Q3 revenue and merchandise volume miss estimates

Chevron Maintains 2028 Data Center Power Target Despite Texas Pause

Infighting Spikes In Telangana Congress, Leaders Have Public Altercation In Delhi

Lattice leaps on Q3 beat, but analysts have divergent takes

Rocket One's Hoth Therapeutics Reports Strong HT-001 Efficacy Results, Ends Phase 2a Early and Plans to Pursue Phase 3 to Bring Treatment to Cancer Pa

ASML Surges 48% in the Past Year: How Should You Play the Stock Now?

Jazz Pharmaceuticals (JAZZ) Could Be 27% Undervalued As Record Revenue Lifts Outlook

Trump focuses on Reflecting Pool in final public speech before midterms

Energy Transition Today - Australia's Wind Energy Surge Driven By Coal Phase-Out

The SEC Should Block Anthropic's IPO to Protect the Public

U.S. judge dismisses Trump administration's Harvard admissions probe case

Lattice Semiconductor Corp (LSCC) (Q3 2026) Earnings Call Highlights: Record Revenue of $291 ...

Bayer Q3 sales, EBITDA beat estimates; raises 2026 earnings and cash flow outlook

From "Can Be Called" to "Dare to Entrust": The Triple Trust of Instrumentation & Electronics Intelligent Computing Cloud's Token Factory

XPeng Shares Jump as EV Maker Scores Major Robotaxi Breakthrough

Lattice Semiconductor (LSCC) Stock Looks Fully Valued After Fresh AI Demand News

Bitcoin is back below $77K, down 1.7%, even as WTI crude slid 7% on hopes of a US-Iran diplomatic resolution. A 7% oil drop and higher stock open stil

Onsemi is targeting more than $3B in AI data center revenue by 2030, backed by a $600M Ferric deal. That is a real re-rating lever for a name still pr

Strategy spends triple its weekly Bitcoin outlay on STRC buybacks

ETFs to Watch as Amazon Shares Slip Following Q3 Earnings Miss

New Phase 2 REC-4881 Data Presented at CGA-IGC Show Deep, Durable Polyp Burden Reductions in FAP, with Activity Across the GI Tract and in Larger, Hig

AEM Q3 Earnings Beat Estimates on Higher Gold Prices

Intel's foundry push hits its critical test with the stock down 45% in October. The market is done paying for a turnaround story without proof, so the

Strategy Resumes Bitcoin Buys With $66M Purchase

Reliance shares surge 7%, eye best single-day gain in over 2 years: What's driving the rally?

Kalshi expects to launch single-stock perpetual futures in the next few days, with its CFTC application's standard 45-day review ending today. Andy Ro

Cheniere Energy Q3 Earnings Miss on Rising Costs, Revenues Beat

How did 2010 agreement land Ram Gopal Varma in ₹29 crore legal case, and why has Eclatant Films warned OTT platforms

Stocks are jumping as oil tumbles into the midterms and tech rebounds. Cheaper crude plus a tech bounce is a relief trade, not a regime change. Watch

Judge tosses case against ex-FBI officials accused of lying to Congress about Hunter Biden investigation

Vicapsys Life Sciences Provides Shareholder Update on VICAPSYN(TM) Program Advancing Toward Phase 1 Human Clinical Trial, Vertically Integrated With t

China's First Frontier AI Export Controls: Mofcom Announcement No. 48

Valuation Compression Pulls Down KLA (KLAC) Despite Raised Outlook

AbbVie (ABBV) Lands Phase 3 Migraine Study Win In The Lancet Neurology

Day After Opposition Protest, Talk Of NCP Merger At Amit Shah Meeting: Sources

iShares iBonds Dec 2044 Term Treasury ETF declares monthly distribution of $0.0950

iShares iBonds Dec 2045 Term Treasury ETF declares monthly distribution of $0.0814